Essential Updates in Grading, Morphotyping, Reporting, and Staging of Prostate Carcinoma for General Surgical Pathologists

Gladell P. Paner, Jatin Gandhi, Bonnie Choy, Mahul Amin

Research output: Contribution to journalArticle

Abstract

CONTEXT.—: Within this decade, several important updates in prostate cancer have been presented through expert international consensus conferences and influential publications of tumor classification and staging. OBJECTIVE.—: To present key updates in prostate carcinoma. DATA SOURCES.—: The study comprised a review of literature and our experience from routine and consultation practices. CONCLUSIONS.—: Grade groups, a compression of the Gleason system into clinically meaningful groups relevant in this era of active surveillance and multidisciplinary care management for prostate cancer, have been introduced. Refinements in the Gleason patterns notably result in the contemporarily defined Gleason score 6 cancers having a virtually indolent behavior. Grading of tertiary and minor higher-grade patterns in radical prostatectomy has been clarified. A new classification for prostatic neuroendocrine tumors has been promulgated, and intraductal, microcystic, and pleomorphic giant cell carcinomas have been officially recognized. Reporting the percentage of Gleason pattern 4 in Gleason score 7 cancers has been recommended, and data on the enhanced risk for worse prognosis of cribriform pattern are emerging. In reporting biopsies for active surveillance criteria-based protocols, we outline approaches in special situations, including variances in sampling or submission. The 8th American Joint Commission on Cancer TNM staging for prostate cancer has eliminated pT2 subcategorization and stresses the importance of nonanatomic factors in stage groupings and outcome prediction. As the clinical and pathology practices for prostate cancer continue to evolve, it is of utmost importance that surgical pathologists become fully aware of the new changes and challenges that impact their evaluation of prostatic specimens.

Original languageEnglish (US)
Pages (from-to)550-564
Number of pages15
JournalArchives of pathology & laboratory medicine
Volume143
Issue number5
DOIs
StatePublished - May 1 2019

Fingerprint

Neoplasm Staging
Prostate
Prostatic Neoplasms
Carcinoma
Neoplasm Grading
Giant Cell Carcinoma
Clinical Pathology
Neuroendocrine Tumors
Prostatectomy
Publications
Neoplasms
Referral and Consultation
Joints
Biopsy
Pathologists

All Science Journal Classification (ASJC) codes

  • Pathology and Forensic Medicine
  • Medical Laboratory Technology

Cite this

Essential Updates in Grading, Morphotyping, Reporting, and Staging of Prostate Carcinoma for General Surgical Pathologists. / Paner, Gladell P.; Gandhi, Jatin; Choy, Bonnie; Amin, Mahul.

In: Archives of pathology & laboratory medicine, Vol. 143, No. 5, 01.05.2019, p. 550-564.

Research output: Contribution to journalArticle

@article{8ef8bc6cbb97473b83feb709770352e4,
title = "Essential Updates in Grading, Morphotyping, Reporting, and Staging of Prostate Carcinoma for General Surgical Pathologists",
abstract = "CONTEXT.—: Within this decade, several important updates in prostate cancer have been presented through expert international consensus conferences and influential publications of tumor classification and staging. OBJECTIVE.—: To present key updates in prostate carcinoma. DATA SOURCES.—: The study comprised a review of literature and our experience from routine and consultation practices. CONCLUSIONS.—: Grade groups, a compression of the Gleason system into clinically meaningful groups relevant in this era of active surveillance and multidisciplinary care management for prostate cancer, have been introduced. Refinements in the Gleason patterns notably result in the contemporarily defined Gleason score 6 cancers having a virtually indolent behavior. Grading of tertiary and minor higher-grade patterns in radical prostatectomy has been clarified. A new classification for prostatic neuroendocrine tumors has been promulgated, and intraductal, microcystic, and pleomorphic giant cell carcinomas have been officially recognized. Reporting the percentage of Gleason pattern 4 in Gleason score 7 cancers has been recommended, and data on the enhanced risk for worse prognosis of cribriform pattern are emerging. In reporting biopsies for active surveillance criteria-based protocols, we outline approaches in special situations, including variances in sampling or submission. The 8th American Joint Commission on Cancer TNM staging for prostate cancer has eliminated pT2 subcategorization and stresses the importance of nonanatomic factors in stage groupings and outcome prediction. As the clinical and pathology practices for prostate cancer continue to evolve, it is of utmost importance that surgical pathologists become fully aware of the new changes and challenges that impact their evaluation of prostatic specimens.",
author = "Paner, {Gladell P.} and Jatin Gandhi and Bonnie Choy and Mahul Amin",
year = "2019",
month = "5",
day = "1",
doi = "10.5858/arpa.2018-0334-RA",
language = "English (US)",
volume = "143",
pages = "550--564",
journal = "Archives of Pathology and Laboratory Medicine",
issn = "0003-9985",
publisher = "College of American Pathologists",
number = "5",

}

TY - JOUR

T1 - Essential Updates in Grading, Morphotyping, Reporting, and Staging of Prostate Carcinoma for General Surgical Pathologists

AU - Paner, Gladell P.

AU - Gandhi, Jatin

AU - Choy, Bonnie

AU - Amin, Mahul

PY - 2019/5/1

Y1 - 2019/5/1

N2 - CONTEXT.—: Within this decade, several important updates in prostate cancer have been presented through expert international consensus conferences and influential publications of tumor classification and staging. OBJECTIVE.—: To present key updates in prostate carcinoma. DATA SOURCES.—: The study comprised a review of literature and our experience from routine and consultation practices. CONCLUSIONS.—: Grade groups, a compression of the Gleason system into clinically meaningful groups relevant in this era of active surveillance and multidisciplinary care management for prostate cancer, have been introduced. Refinements in the Gleason patterns notably result in the contemporarily defined Gleason score 6 cancers having a virtually indolent behavior. Grading of tertiary and minor higher-grade patterns in radical prostatectomy has been clarified. A new classification for prostatic neuroendocrine tumors has been promulgated, and intraductal, microcystic, and pleomorphic giant cell carcinomas have been officially recognized. Reporting the percentage of Gleason pattern 4 in Gleason score 7 cancers has been recommended, and data on the enhanced risk for worse prognosis of cribriform pattern are emerging. In reporting biopsies for active surveillance criteria-based protocols, we outline approaches in special situations, including variances in sampling or submission. The 8th American Joint Commission on Cancer TNM staging for prostate cancer has eliminated pT2 subcategorization and stresses the importance of nonanatomic factors in stage groupings and outcome prediction. As the clinical and pathology practices for prostate cancer continue to evolve, it is of utmost importance that surgical pathologists become fully aware of the new changes and challenges that impact their evaluation of prostatic specimens.

AB - CONTEXT.—: Within this decade, several important updates in prostate cancer have been presented through expert international consensus conferences and influential publications of tumor classification and staging. OBJECTIVE.—: To present key updates in prostate carcinoma. DATA SOURCES.—: The study comprised a review of literature and our experience from routine and consultation practices. CONCLUSIONS.—: Grade groups, a compression of the Gleason system into clinically meaningful groups relevant in this era of active surveillance and multidisciplinary care management for prostate cancer, have been introduced. Refinements in the Gleason patterns notably result in the contemporarily defined Gleason score 6 cancers having a virtually indolent behavior. Grading of tertiary and minor higher-grade patterns in radical prostatectomy has been clarified. A new classification for prostatic neuroendocrine tumors has been promulgated, and intraductal, microcystic, and pleomorphic giant cell carcinomas have been officially recognized. Reporting the percentage of Gleason pattern 4 in Gleason score 7 cancers has been recommended, and data on the enhanced risk for worse prognosis of cribriform pattern are emerging. In reporting biopsies for active surveillance criteria-based protocols, we outline approaches in special situations, including variances in sampling or submission. The 8th American Joint Commission on Cancer TNM staging for prostate cancer has eliminated pT2 subcategorization and stresses the importance of nonanatomic factors in stage groupings and outcome prediction. As the clinical and pathology practices for prostate cancer continue to evolve, it is of utmost importance that surgical pathologists become fully aware of the new changes and challenges that impact their evaluation of prostatic specimens.

UR - http://www.scopus.com/inward/record.url?scp=85065315651&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065315651&partnerID=8YFLogxK

U2 - 10.5858/arpa.2018-0334-RA

DO - 10.5858/arpa.2018-0334-RA

M3 - Article

C2 - 30865487

AN - SCOPUS:85065315651

VL - 143

SP - 550

EP - 564

JO - Archives of Pathology and Laboratory Medicine

JF - Archives of Pathology and Laboratory Medicine

SN - 0003-9985

IS - 5

ER -